✦ LIBER ✦

Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: Evidence for involvement of a serine protease

Book ID: 123460066
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 298 KB
Volume: 3
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(87)80216-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Creatine kinase BB and beta-2-microglobu

Creatine kinase BB and beta-2-microglobulin as markers of CNA metastases in patients with small-cell lung cancer

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Modification of β2-microglobulin in seru

Modification of β2-microglobulin in serum from patients with small cell carcinoma of the lung — correlation with the clinical course

✍ Mogens H. Nissen; Torben Plesner; Mikael Rørth 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 667 KB

A randomized Phase II study of interleuk

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer

✍ Tester, William J.; Kim, Kyung Mann; Krigel, Robert L.; Bonomi, Philip D.; Glick 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 98 KB

488 Neuropsychometric impairment in pati

488 Neuropsychometric impairment in patients with small cell lung cancer (SCLC): Evidence from a randomised trial of prophylactic cranial irradiation (PCI)

✍ Cull, A.; Gregor, A.; Stephens, R.J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 141 KB

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix

HER2 status in non-small cell lung cance

HER2 status in non-small cell lung cancer (NSCLC): results from the patient screening for enrolment to a phase 2 study of herceptin

✍ P. Heinmoeller; C. Gross; C. Schmidtgen; K. Beyser; C. Nordhoff; A. Bockholt; M. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 339 KB